Ring chromosome 20 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1444Q93.2
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ring chromosome 20 syndrome (r(20) syndrome) is a rare chromosomal disorder caused by the formation of a ring-shaped chromosome 20, in which the two ends of the chromosome fuse together, often with loss of genetic material at the tips. This condition primarily affects the nervous system and is characterized by refractory epilepsy, which is often the hallmark feature. Seizures typically begin in childhood and are frequently resistant to standard antiepileptic medications. The most distinctive seizure type associated with this syndrome is prolonged episodes of non-convulsive status epilepticus, often presenting as subtle behavioral changes, confusion, or staring episodes, as well as complex partial seizures, particularly occurring during sleep. Electroencephalographic (EEG) findings often show prolonged episodes of high-voltage slow waves and epileptiform discharges, especially during sleep. Cognitive and behavioral difficulties are common in ring chromosome 20 syndrome. Many affected individuals experience intellectual disability ranging from mild to moderate, though some may have normal intelligence, particularly if the ring chromosome is present in mosaic form (meaning only some cells carry the ring chromosome). Behavioral problems, including attention difficulties, anxiety, and autistic features, have been reported. Some patients may also experience progressive cognitive decline associated with ongoing seizure activity. Dysmorphic facial features are generally absent or very subtle, which can make clinical recognition challenging before genetic testing is performed. There is currently no cure for ring chromosome 20 syndrome. Treatment focuses primarily on seizure management, though epilepsy in this condition is notoriously difficult to control with conventional antiepileptic drugs. Medications such as valproate, lamotrigine, and clobazam may provide partial benefit. Vagus nerve stimulation (VNS) has been explored as an adjunctive therapy in some patients with variable results. The ketogenic diet has also been tried in some cases. Supportive care including educational support, neuropsychological assessment, and behavioral interventions are important components of management. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Non-convulsive status epilepticus without comaHP:0032671Focal motor seizureHP:0011153Nocturnal seizuresHP:0031951Epileptic encephalopathyHP:0200134
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ring chromosome 20 syndrome.

View clinical trials →

No actively recruiting trials found for Ring chromosome 20 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ring chromosome 20 syndrome community →

Specialists

15 foundView all specialists →
HO
Hideyuki Ohtani
Specialist
1 Ring chromosome 20 syndrome publication
TN
Takuji Nishida
Specialist
1 Ring chromosome 20 syndrome publication
TY
Tokito Yamaguchi
Specialist
1 Ring chromosome 20 syndrome publication
EY
Etsuko Yamazaki
Specialist
1 Ring chromosome 20 syndrome publication
HI
Hitoshi Ikeda
Specialist
1 Ring chromosome 20 syndrome publication
HI
Hiroko Ikeda
Specialist
1 Ring chromosome 20 syndrome publication
NK
Norihiko Kawaguchi
Specialist
1 Ring chromosome 20 syndrome publication
SM
Satoshi Mizutani
Specialist
1 Ring chromosome 20 syndrome publication
NU
Naotaka Usui
Specialist
1 Ring chromosome 20 syndrome publication
KI
Katsumi Imai
Specialist
1 Ring chromosome 20 syndrome publication
YI
Yushi Inoue
Specialist
1 Ring chromosome 20 syndrome publication
KT
Kentaro Tokumoto
Specialist
1 Ring chromosome 20 syndrome publication
SP
Stefano Parravicini
Specialist
1 Ring chromosome 20 syndrome publication
LP
Ludovica Pasca
Specialist
1 Ring chromosome 20 syndrome publication
MZ
Martina Paola Zanaboni
Specialist
1 Ring chromosome 20 syndrome publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ring chromosome 20 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ring chromosome 20 syndromeForum →

No community posts yet. Be the first to share your experience with Ring chromosome 20 syndrome.

Start the conversation →

Latest news about Ring chromosome 20 syndrome

No recent news articles for Ring chromosome 20 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ring chromosome 20 syndrome

What is Ring chromosome 20 syndrome?

Ring chromosome 20 syndrome (r(20) syndrome) is a rare chromosomal disorder caused by the formation of a ring-shaped chromosome 20, in which the two ends of the chromosome fuse together, often with loss of genetic material at the tips. This condition primarily affects the nervous system and is characterized by refractory epilepsy, which is often the hallmark feature. Seizures typically begin in childhood and are frequently resistant to standard antiepileptic medications. The most distinctive seizure type associated with this syndrome is prolonged episodes of non-convulsive status epilepticus,

How is Ring chromosome 20 syndrome inherited?

Ring chromosome 20 syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Ring chromosome 20 syndrome typically begin?

Typical onset of Ring chromosome 20 syndrome is childhood. Age of onset can vary across affected individuals.

Which specialists treat Ring chromosome 20 syndrome?

15 specialists and care centers treating Ring chromosome 20 syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.